Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists (Q34183010)

31 July 2017

title

Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists (English)

1 reference

31 July 2017

1 reference

Kiran Kumar Mustyala

1 reference

31 July 2017

Annapurna Renee Chitturi

series ordinal

1 reference

31 July 2017

Prameela Subhashini Naikal James

series ordinal

1 reference

31 July 2017

Uma Vuruputuri

series ordinal

1 reference

31 July 2017

language of work or name

1 reference

2 March 2012

1 reference

Journal of Receptors and Signal Transduction

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

102-113

1 reference

Adenosine receptors as therapeutic targets

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Purinergic signalling in the nervous system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Structure and function of adenosine receptors and their genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

The role and regulation of adenosine in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Adenosine in the spinal cord and periphery: release and regulation of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Interaction of mechanisms involving epoxyeicosatrienoic acids, adenosine receptors, and metabotropic glutamate receptors in neurovascular coupling in rat whisker barrel cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Targeting adenosine A2A receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Purines, the carotid body and respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Adenosine and sleep-wake regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Cloning and expression of the A2a adenosine receptor from guinea pig brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Characterization and expression of the human A2a adenosine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Adenosine, an endogenous distress signal, modulates tissue damage and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Novel pharmacological targets for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Involvement of adenosine A2A receptor in sleep promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Computational validation of the importance of absolute stereochemistry in virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Automated pharmacophore identification for large chemical data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Virtual screening of chemical libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Identification of novel selective antagonists for cyclin C by homology modeling and virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Virtual screening in drug discovery -- a computational perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.660532

10.3109/10799893.2012.660532

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference